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Abstract
Background: Obsessive-compulsive disorder (OCD) segregates in families. It follows a complex model of genetic transmission, which involves the influence 
of several small effect genes interacting with the environment. Methods: A systematic review of genetic association studies in OCD was performed. Articles 
published until 2012 were searched in the databases PubMed, Embase and ScieLO using the terms of MeSH and its associates or synonyms for “obsessive-
compulsive disorder”, “gene” and “genetic association studies”. Results: We selected 105  papers and described their main results grouped as genes related to: 
serotonin, dopamine, glutamate, GABA, white matter, immune system, hormones and other genes. Discussion: There is high variability between findings of 
association studies among the several candidate genes studied in OCD. Glutamate-related genes are promising candidates for OCD, but there is no conclusive 
association between any of the candidate genes studied and OCD. Association studies with large sample size, evaluation of more homogeneous subgroups of 
phenotype and meta-analyses are still needed.
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Resumo
Contexto: O caráter familial do transtorno obsessivo-compulsivo (TOC) já é bem estabelecido. Ele segue o modelo complexo de transmissão genética que 
envolve a influência de diversos genes de pequeno efeito em interação com o ambiente. Métodos: Foi realizada uma revisão sistemática de estudos de associação 
genética com o TOC mediante busca de artigos publicados até 2012 nas bases de dados: PubMed, Embase e SciELO, usando os termos MeSH, seus associados 
ou sinônimos para “obsessive-compulsive disorder”, “gene” e “genetic association studies”. Resultados: Foram selecionados 105  artigos cujos principais resultados 
foram agrupados em grupos de genes relacionados a serotonina, dopamina, glutamato, GABA, substância branca, hormônios, sistema imune e outros genes 
(MAO-A, BNDF, COMT). Conclusão: Há grande variabilidade nos achados de estudos de associação entre os diversos genes candidatos estudados e o TOC. 
Genes relacionados às vias glutamatérgicas são candidatos promissores, porém não há associação conclusiva entre nenhum dos genes candidatos estudados 
e o TOC. Estudos de associação com grande tamanho amostral, avaliação de subgrupos mais homogêneos do fenótipo e metanálises ainda são necessários. 
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Introduction
Obsessive-compulsive disorder (OCD) is the fourth most common 
psychiatric disorder with a lifetime prevalence between 2.0% and 
2.5%1. According to the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) criteria, OCD is characterized by obsessions 
and/or compulsions. These obsessions / compulsions occur for at 
least an hour a day, cause functional interference and significant 
distress or social impairment2. OCD is a chronic disorder and 
manifests regardless of sex, race, intelligence, marital status, socio-
economic status, religion or nationality. The cross-cultural studies 
show that the OCD symptoms are similar in different population 
and cultures3, supporting the idea that biological and genetic factors 
can contribute to its etiology. Although psychological theories have 
grounded the emergence of the OCD concept4 there is increasing 
evidence that it is mediated by a genetic-environmental interac-
tion. In fact, the involvement of genetic factors in the etiology of 
OCD has been emphasized since the first descriptions of OCD5. 
Studies in Human Genetics Psychiatric genetics seeks to under-
stand how biological and environmental factors interact to cause 
a specific psychiatric disorder. The study designs in human genet-
ics assessing etiologic factors of psychiatric disorders are divided 
into two groups: genetic-epidemiological studies and molecular 
genetic studies.
Genetic-epidemiological studies
Genetic-epidemiological psychiatry is a science that deals with 
“causes, distribution and control of disease among family groups and 
with genetic causes of diseases in populations”6. Genetic epidemiol-
ogy uses as methodology the family studies, twin or adoption studies, 
or segregation analyses.
Family studies
Uses the case-control study design. Thus, there is a comparison be-
tween the frequency of the disorder in relatives of patients with the 
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investigated phenotype (case probands) and the frequency of that 
disorder in relatives of individuals who do not have the investigated 
phenotype (control probands). If the frequency of the studied phe-
notype is significantly higher in the group of case probands’ relatives, 
it can be said that there is familial aggregation6. A meta-analysis of 
studies in OCD families, involving 312 probands and their 1209 
first-degree relatives, found a cumulative risk of 8.2% among “case” 
relatives and 2% among “control” family members, with an odds ratio 
of 4 (95% CI = 2.2, 7.1) to present OCD7.
Twin studies compare the concordance for certain phenotypes 
between monozygotic (MZ), with the correlation observed between 
dizygotic (DZ) twins. The assumption is that MZ and DZ twins suf-
fer similar environmental influence; however MZ twins share 100% 
of genome, while DZ twins share about 50%. Thus, in phenotypes 
more influenced by the environment, the concordance rates between 
MZ and DZ were similar; whereas in phenotypes more influenced 
by a genetic component, the MZ concordance rate would be higher 
than in DZ8. Furthermore, twin studies also allow us to estimate 
heritability (h2), that is, the size of the genetic effect in determin-
ing the studied phenotype. Data from 28 twin studies in OCD have 
shown that obsessive-compulsive symptoms (OCS) have genetic 
contributions with heritability rates of 45% to 65% in children and 
27% to 47% in adults9.
Adoption studies
Allow greater separation between genetic and environmental factors 
in the disorder etiology, since children do not share the home with 
their biological parents. Its main limitation is that the homes that 
embrace the adopted children do not represent higher risk environ-
ments (e.g., environments of extreme poverty and deprivation)8. 
Generally adoption studies assess the history of mental disorders in 
the biological family and correlate with psychosocial protective or 
risk factors in the adoptive family8. As far as we know, there is no 
adoption study in OCD.
Segregation analysis
Assesses whether the transmission of a studied phenotype, over the 
family generations, can be explained by a Mendelian genetic model. 
Some of the models evaluated by genetic segregation analysis are: no 
transmission, autosomal dominant, autosomal recessive, polygenic 
(multiple genes of small effect); multifactorial or mixed (multiple 
genes of small effect added to environmental influences). The most 
accepted segregation model for OCD is the complex or mixed model, 
which involves the influence of many genes of small effect interacting 
with the environment6.
Molecular genetic studies
Several studies in genetic epidemiology have been consistent in 
stating that OCD is a familial disorder. With the advent of modern 
molecular biology techniques, there has been growing interest in 
identifying which genes are involved in OCD etiology. Most genetic 
studies in OCD evaluate its association with genes involved in OCD-
related brain circuits.
Linkage studies
Evaluate whether a particular genetic marker with known location 
co-segregates with the studied phenotype over generations. When 
two loci, located on the same chromosome, are very close to each 
other, they tend to be transmitted together (linked) as there are low 
odds of recombination between homologous chromosomes (crossing 
over). So, if the affected family members always inherit the studied 
genetic marker, the gene responsible for the disease is probably lo-
cated near the marker. The main limitation of the study is the need to 
evaluate several family generations, with multiple affected members, 
in “complex” disorders such as OCD6.
Association studies
Are designed to detect specific genes involved in a disorder. With 
the case-control design, whether there is a significant difference 
in an allelic variant distribution among affected (cases) and unaf-
fected individuals (controls)10 is evaluated. The main limitation of 
the case-control association analysis is population stratification 
bias, which is when cases and controls are not ethnically matched. 
Family-based association studies, comparing the proband with the 
own biological parents, a “trio”, controls the population stratification 
bias. These analyses, called Transmission Disequilibrium Test (TDT) 
and the Haplotype Relative Risk (HRR)6, compare the frequency of 
transmitted and untransmitted alleles from parents to the proband.
Several markers covering the entire genome can be evaluated in 
a Genomewide association study. However, most association studies 
evaluate polymorphisms located in candidate genes. Polymorphism 
is a DNA sequence variation found that is present in more than 
1% of the population. The polymorphisms may be by exchange of 
one nitrogenous base (single nucleotide polymorphism – SNP) or 
by varying the number of repetitions of a sequence of bases in a 
particular locus (variable number of tandem repeats – VNTR). The 
choice of a candidate gene to be investigated on a particular disorder 
can be based on clinical features or pathophysiology.
This review aims to present the results of studies of the associa-
tion between candidate genes and OCD.
Methods
We performed a systematic review by searching for articles published 
up to May 4, 2012 in databases: PubMed, Embase and SciELO using 
MeSH terms, its associates or synonyms for “obsessive-compulsive 
disorder”, “gene” and “genetic association studies”.
Each term was searched separately (PubMed: term 1 = 1,662,401 
results; term results 2 = 14,124; term results 3 = 14 124; Embase: 
term 1 = 227,040 results; term results 2 = 19,244; term results 3 = 
16 843; SciELO: term 1 = 4719 results, results term 2 = 209, 3 = 181 
term results) and later the three searches were combined using the 
word “AND” resulting in 202 references in PubMed, 49 references in 
Embase and 7 references in SciELO. References were sent to the refer-
ence management program EndNote® and duplicates were discarded. 
References were selected and two independent researchers (ASS and 
RPL) assessed the full texts based on the inclusion criteria, which 
are: 1) Original studies or reviews about the association with candi-
date genes 2) The probands were required to meet criteria for DSM 
III or DSM IV to obsessive-compulsive disorder, 3) Studies should 
be written in English, Portuguese or Spanish (Figure 1): flowchart 
of search and selection of articles. The list of references of selected 
studies was examined to evaluate studies not found in the database.
Results
We selected 105  studies whose main findings are summarized below.
Genes related to serotonin
Gene serotonin transporter (SLC6A4, 5-HTT, SERT, 5HTTLPR)
Chromosome: 17; location: 17q11.1-q12
The serotonin transporter gene is an important candidate gene, since 
it represents the primary target for serotonin reuptake inhibitors 
(SRI). Hanna et al. reported an association between blood levels of 
serotonin and specific genotypes of 5HTT in families of patients 
with OCD11.
A polymorphic region, comprising repeated elements 16, is de-
scribed next to the start of zone 5HTT gene transcription, the 5-HT-
TLPR polymorphism is an insertion or deletion of 44-bp elements 
involving repeated 6 to 8 times generating two functional alleles : A 
short allele (S) and the long allele (L)12. However, Hu and co-workers 
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reported that 5-HTTLPR polymorphism is functionally triallelic, 
resulting from the substitution of A for G in the G allele13. Other 
polymorphisms of this gene that correspond to a variable number 
Table 1. Association studies between obsessive-compulsive disorder and polymorphisms of the serotonin transporter gene (5HTT) and the promoter of 
the serotonin transporter (5HTTLPR)
Study design Genotype Population Phenotype Sample
Cases/Controls
Results Reference
CC 5HTTLPR Italian OCD 180/112 NS (158)
CC 5HTTLPR Brazilian OCD 79/202 NS (23)
CC/FB 5HTTLPR French/German OCD 106 families
86/171
NS (159)
CC/FB 5HTTLPR Mexican OCD 43 families
115/136
NS (160)
FB 5HTTLPR German Early onset 
OCD
64 families NS (28)
CC 5HTTLPR, VNTR Indian OCD 93/92 Association between  
5-HTTLPR  and OCD 
severity  
(p = 0.036); VNTR: NS
(161)
CC 5HTTLPR, VNTR Korean OCD 148/157 NS (21)
CC 5HTTLPR, VNTR Caucasian OCD 295/657 NS (89)
CC 5HTTLPR, VNTR Spanish 
Caucasians
OCD 97 OCD/570 
psychiatric controls 
/406 healthy controls
More 12/12 e 12/10 
genotypes in patients 
with OCD.
(162)
CC 5HTTLPR Spanish Caucasians OCD 99 OCD/456 
psychiatric controls 
/420 healthy controls
5HTTLPR: NS;
VNTR: More 12/12, 
12/10 and 12/9 
genotypes  in patients 
with OCD
(19)
CC 5HTLLPR Han Chinese OCD 207/275 NS (163)
CC 5HTLLPR Korean OCD 124/171 The L allele in OCD 
presented higher 
scores on symptoms 
religious/somatic  
(p = 0.005)
(164)
OCD: obsessive-compulsive disorder; NS: nonsignificant, CC: case-control; FB: family-based; 5-HTTLPR: polymorphism of the promoter region of the serotonin transporter gene.
Figure 1. Flowchart of studies search and selection.
of tandem repeats (VNTR) in the 17 base pair (bp) are termed the 
VNTR STin2 and involve different alleles14. Studies of the gene 5HTT 
are described in table 1.
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Serotonin receptor type 2A (HTR2A, 5-HT2A)
Chromosome: 13; location: 13q14-q21
Evidence suggests that an action of the serotonin 2A receptor in OCD 
run reports of benefit in the use of hallucinogens (potent stimulants 
of 5HT2A) and the tendency of clozapine trigger SOC in patients 
with schizophrenia15.
The two most studied polymorphisms in OCD are -1438 A/G 
and T102C. Some studies show an association between OCD and 
AA allele polymorphism -1438 G/A in women16,17 and in a sample of 
children and adolescents18. These results were not replicated in other 
studies15,19. Liu et al. studied a sample of 103 Chinese trios and found 
a significant association between OCD and 5HT2A polymorphism-
1438G/A (p = 0.0389), and a transmission disequilibrium in the 
late-onset group (p = 0.0132) and in the male group (p = 0.0255)20. 
Regarding the T102C variant, several studies found no significant 
association with OCD15,21. Tot et al. found that genotypes and T102T 
variant -1438 AA genotype A/G were associated with an increased 
severity of OCD22. Meira-Lima et al. also found that silent C516T 
variant was associated with OCD23.
Serotonin receptor type 1B (HTR1B, 5HT1B)
Chromosome: 6; location: 6q13
The beneficial effects of atypical antipsychotic drugs and hallucino-
gens in 5HT1B were seen in some OCD patients, suggesting that this 
receptor may be involved in the neurobiology of OCD.
World et al. found a preferential transmission of the G861 
allele for OCD24 and confirmed these findings in a longitudinal 
study25. Camarena et al. also found a preferential transmission 
of the variant G861 C861 compared to the group with the high-
est scores of the YBOCS (Yale-Brown Obsessive Compulsive 
Scale), although no association was found with OCD26. Liu 
et al. found an association of this gene with early onset OCD 
(p = 0.0389)20. Meanwhile, other studies have two negative 
findings27,28. Preliminary findings of an association between 
allele G861 and symptoms of order/arrangement/symmetry 
let the suggestion for more refined phenotypic analyses in 
genetic studies29.
Receptor 5-hydroxytryptamine (serotonin) type 2C (HTR2C, 
5HT2C)
Chromosome: X; location: Xq24
Chronic treatment of OCD with SSRIs may result in reduced dopa-
mine transmission through activation of mesocorticolimbic 5HT2C, 
which may represent an important event for the therapeutic efficacy 
of SSRIs30,31. Study in mice, which presented 5HT2C gene deletion, 
showed similar behavior to compulsive symptoms32. Tsaltas and 
co-workers showed exacerbation of SOC after administration of 
m-CPP (5HT2C agonist)33. Two studies of the association between 
a structural variant in the N-terminal extracellular region of the re-
ceptor and the 5HT2C TOC findings were negative34,35. This variant 
resulting from the substitution of the amino acid cysteine  for serine 
at position 2336, but does not have a defined function34,37.
Tryptophan hydroxylase 1 (TPH1)
Chromosome: 11; location: 11p15.3-p14
Tryptophan hydroxylase (TPH) is an important step in the synthesis 
of 5HTT, and in this way is an important candidate gene. There are 
two forms of expression: TPH1 and TPH2.
The TPH1 is detected in blood and peripherally in the duode-
num, but is not found in the brain. Two association studies found 
no significant findings between this gene and OCD28,37.
Tryptophan hydroxylase 2 (TPH2)
Chromosome: 12; location: 12q21.1
The TPH2 is detected exclusively in the brain. One study found an 
association between this gene and early-onset OCD38. A Brazilian 
study with 107 patients and 214 controls found no association be-
tween the 8 SNPs evaluated in the TPH2 gene and OCD, but found 
higher prevalence of T-C-T (rs4448731, rs4565946, rs10506645) e 
C-A-T (rs4565946, rs7955501, rs10506645) haplotypes among OCD 
patients39. Among the most studied genes are the genes of the sero-
tonin transporter (5-HTT) and its promoter region (5-HTTLPR). 
A recent meta-analysis assessed the studies with the 5-HTT gene, 
5-HTTLPR, HTR1B, HTR2A and HTR2C in OCD and found that 
the association between OCD and 5HTTLPR polymorphism, when 
considered its 3 allele (OR: 1.251, 95% CI: (1.048 -1.492), p = 0.001), 
and two polymorphisms of the 5-THR2A rs6311 and 6313 (OR: 
1.219, 95% CI: (1.037 to 1.433), p = 0.002) were statistically signifi-
cant, strengthening its possible contribution in the etiology of OCD40.
Dopamine related genes
The serotonergic system has many interrelationships with other neu-
ronal circuits and neurotransmitters41. Dopamine plays an important 
role in the pathophysiology of OCD42 and is involved in an interaction 
with the dopaminergic system in the fronto-thalamic-base ganglion43. 
Such modulation of dopamine transmission made by SSRIs indirectly 
influences the development and OCD43. Pharmacological studies 
have found that dopamine antagonists in combination with SSRIs 
were effective in treating OCD. Animal studies have found that the 
use of dopamine agonists induces stereotypic movements similar 
to some SOC44.
Dopamine transporter gene (DAT1 or SLC6A3)
Chromosome: 5; location: 5p15.3
The dopamine transporter gene has a central role in the removal of 
midbrain dopamine synapses. The diffusion and uptake of dopamine 
by DAT1 changes the magnitude, duration, and spatial configura-
tion of the receptor activation induced by the transmitter, thereby 
modifying dopaminergic neurotransmission15. Mice with deletion 
of DAT sequential display stereotypic behaviors45; similar to those 
observed in basal ganglia disorders such as OCD and Tourette 
syndrome. DAT1 has a VNTR polymorphism in the 40bp repeat 
having 3 to 11 repetitions in the 3 “untranslated” that can influence 
gene expression and protein levels in brain DAT146. The studies that 
investigated the association between DAT and TOC were negative 
findings47,48 (Table 2).
Dopamine receptor D2 (DRD2)
Chromosome: 11; location: 11q23
The dopamine D2 receptor (DRD2) is found at high levels in the 
basal ganglia, which makes it a candidate gene for the pathophysi-
ology of OCD. Although some studies have found no association 
between this gene and OCD, Nicolini et al. found a higher fre-
quency of the variant in the DRD2 A2A2 OCD + tics (p = 0.008)49. 
In another study, Nicolini et al. found an association between the 
A allele of the DRD2 TaqIA2 (p = 0.01) and TOC and an excess of 
homozygotes A2A2 in OCD + tics group (p = 0.001)50. Denys et al. 
found a higher frequency of the DRD2 A2 allele only in men with 
OCD (p = 0.02)51 (Table 2).
181Sampaio AS, et al. / Rev Psiq Clín. 2013;40(5):177-90
Table 2. Association studies between obsessive-compulsive disorder and genes of dopamine receptors 2, 3 and 4 (DRD2, DRD3 and DRD4) and dopamine 
transporter (DAT1)
Study Design Population Phenotype Samples
Cases/Controls
Results Reference
CC Canadian OCD 100/18 Association between OCD and the DRD4 gene 
(p = 0.02) which was not found after correction 
for multiple testing; no associations with 
DAT1, DRD2 or DRD3
(52) 
CC Afrikaners OCD 71/129 NS (165)
CC Ashkenazi and 
nonnon-Ashkenazi 
Jews
OCD 75/172 NS (37)
FB
CC
French OCD 55 trios
49 OCD (17 OCD + 
tics)/63 controls
DRD4: No transmission of the 2 repeats allele/
Lower frequency of the 2 repeats allele in 
patients with OCD without tic (p = 0.005)
(55)
CC Afrikaners OCD 252/180 DRD4: the allele of 7 repeats was associated 
with early onset OCD  
(p = 0.02)
(56)
CC Korean OCD 115/160 Higher frequency of the 2 repeats allele in 
patients with OCD (p = 0.04)
  (156)
CC Mexican OCD + tics 49 OCD-tics/12 OCD 
+ tics
DRD4: higher frequency of the 7 repeats allele 
(p = 0.02)
(54)
CC Mexican OCD + tics 54 OCD-tics/12 OCD 
+ tics/54
 
DRD2: Association between OCD and the most 
frequent allele, A2 (p = 0.01); Excess of allele 
A2 homozygosis  
(p = 0.001). DRD4: higher frequency of the 7 
repeats allele (p = 0.02) and of the haplotype 
A2R7 (p = 0.02) in the OCD + tics group  
(50)
CC Mexican OCD 67 (12 with tics)/54 DRD2: higher frequency of A2 homozygosis 
in OCD + tics group (p = 0.008); nonsignificant 
for DRD3
(49)
CC Dutch OCD 150 (56 male)/150 (79 
male)
Higher frequency of DRD2 A2 allele in male 
OCD patients (p = 0.02)
(51) 
CC Caucasian OCD 97/97 NS (166)
CC,FB Mexican OCD 210/202 DRD4: lower frequency of the 4 repeats allele  
(p = 0.0027)
(57)
FB Caucasian OCD + tics
OCD
38/202
86 families
Higher frequency of the 6 repeats allele in  
OCD + tics group (p = 0.0016)
(58)
FB Chinese Early onset OCD 
OCD
69 trios
103 trios
NS
DRD4: lower frequency in transmission of the 
4 repeats allele (p = 0.003)
NS
(20)
DRD2: gene of Dopamine Receptor D2; DRD3: gene of Dopamine Receptor D3, DRD4: gene of Dopamine Receptor D4, NS: nonsignificant; CC: case-control; FB: family-based; OCD: obsessive-compulsive 
disorder; OCD + tics: obsessive-compulsive disorder in association with tic disorder.
Dopamine D3 receptor (DRD3)
Chromosome: 3; Location: 3q13.3
The antagonism at dopamine D3 receptor has an anxiolytic effect. 
The function and expression of DRD3 is decreased during stress and 
depression, while chronic treatment with SSRI drugs or noradrener-
gic DRD3 mRNA increases, offsetting the effect of the initial stress15. 
The SNP variant most studied is one that leads to the substitution 
of glycine for serine at codon 9 (Ser9Gly), but studies with this gene 
and TOC were found to be negative49,52 (Table 2).
Dopamine receptor D4 (DRD4)
Chromosome: 11; location: 11p15.5
The dopamine receptor D4 (DRD4) is involved in higher brain func-
tions, modulation of synthesis and turnover of brain dopamine. In 
the DRD4 gene encoding there is a VNTR polymorphism (48PB 2 
to 10 tandem repeats) in the third exon, which is of great interest for 
psychiatric studies53. The results of studies of the association between 
DRD4 and TOC are not conclusive. Some studies have found a higher 
frequency of allele 7 repeats in patients with OCD and tics50,54. Millet 
et al. found no transmission of allele 2 repetitions (p = 0.005) and in 
a case-control study, they found an allele frequency of 2 replicates 
significantly lower in OCD patients (p = 0.02)55. Hemmings et al. 
found an association between allele 7 repeats and early-onset OCD (p 
= 0.02)56. Camarena et al. found lower frequency allele of the DRD4 
4 replicates in OCD patients (p = 0.0027) and higher frequency of 
the 6 repeats allele in the group with tics (p = 0.0016)57. Walitza et 
al. found, in a family-based study, lower transmission of allele 4 
repetitions (p = 0.003)58 (Table 2).
Despite evidence of involvement of dopamine in the pathophysi-
ology of OCD, the findings of association studies with dopamine-
related genes were mostly negative. The DRD4 gene has been the 
most studied in OCD with divergent findings. A recent meta-analysis 
found no association between OCD and the genes DAT1, DRD2, 
DRD3 and DRD440.
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Glutamate related genes
Neuroimaging studies in animal models and pharmacological stu-
dies of candidate gene association reinforce the hypothesis of the 
involvement of glutamate in the pathophysiology of OCD. Functional 
neuroimaging studies showed metabolic hyperactivity in the cortico-
striatal-thalamic-cortical circuits. Abnormal levels of glutamate 
have been reported in OCD patients, predominantly in prefrontal 
regions such as the orbitofrontal cortex and its projection areas in 
the striatum59-61. Glutamate levels in the CSF were also significantly 
higher in patients with OCD compared to controls (p = 0.014)62. 
Drugs that modulate glutamate have been recently used as boosters 
of pharmacological treatment of OCD in adults63,64, adolescents and 
children65. In addition, glutamate-related genes as well as serotonin-
related genes had more positive association results replicated until 
date. Given this, the investigation of glutamatergic genes as candidates 
for OCD has been seen as a promising field.
Gene associated protein SAP90/PSD95- 3 - SAPAP3/
DLGAP3
Chromosome: 1; location: 1p35.3-p34.1
The family of proteins associated with SAP90/PSD95 (SAPAP) is a 
component of postsynaptic density (PSD) that interacts with other 
proteins in a complex key-lock glutamatergic synapses. Results from 
studies in mice suggest that SAPAP3 may be involved in the patho-
physiology of OCD and trichotillomania66. The mouse with SAPAP3 
deletion self-developed facial injuries caused secondary to excessive 
grooming behavior, and showed dysfunction in cortical-striatal 
synapses. After these rats received SSRI, such behavior improved. 
Also, the selective striatal expression SAPAP3, mediated by lentivi-
rus, recovered synaptic and behavioral changes of the mutant mice. 
The TOC and pathological grooming such as trichotillomania, have 
similar phenomenological characteristics67.
Since the Welch et al. study have shown an animal model for 
OCD and pathological grooming with knockout SAPAP3 gene 
mice, the correlate human gene (DLGAP1) began to be studied 
as a candidate in OCD66. Boardman et al. evaluated seven poly-
morphisms in the gene encoding the SAPAP3 in individuals with 
OCD (n = 172), trichotillomania (n = 45) and controls (n = 153), 
and found no association68. Among the group with OCD, early 
onset of the disorder and ATAT haplotype (rs11583978-rs7541937-
rs6662980-rs4652867) was positively associated68. Bienvenu et al. 
evaluated 383 families and found an association between four SA-
PAP3 polymorphisms and pathological grooming (onychophagia, 
dermatotilexomania and/or trichotillomania), but not with OCD69. 
Another study sequenced the gene SAPAP3 in 44 patients with 
OCD and trichotillomania, 44 OCD patients and 178 controls 
without trichotillomania, genotyped 6 polymorphisms in an ad-
ditional sample of 281 OCD patients and 751 individuals from the 
general population, and noted an association between OCD and 
A189V polymorphism (p = 0.045)70.
Ionotropic glutamate receptor N-methyl D-aspartate 2B 
(GRIN2B, NMDAR2B)
Chromosome: 12; location: 12p12
GRIN2B is the gene which encodes one subunit of the NMDA 
receptor71. Arnold et al. studied 130 families of OCD patients and 
found that a haplotype consisting of two polymorphisms GRIN2B 
- 5072T/G (p = 0.014) and 5072G-5988T was associated with suscep-
tibility to OCD (p = 0.002) (29). Later they evaluated 16 patients with 
treatment-naive OCD with magnetic resonance imaging and geno-
typed four polymorphisms GRIN2B (rs1019385, rs890, rs1805476 
and rs1805502), and found that rs1019385 was associated with lower 
concentrations of glutamate in the anterior cingulate cortex29.
Glutamate transporter high affinity neuronal/epithelial 
(SLC1A1, EAAC1)
Chromosome: 9; location: 9p24
The SLC1A1, encoding the glutamate transporter high affinity neuro-
nal/epithelial (SLC1A1, EAAC1), is a strong candidate gene is located 
on 9p24 region72. Hanna et al. studied seven families of patients with 
early-onset OCD, found evidence of linkage in the region 9p73. In 
a replication study, Willour et al. genotyped 50 families with OCD 
and found peak connecting two markers: D9S1792 (alpha p = 0.59) 
and D9S1813 (p = 0.006) in the 9p24 region74, only 0, 5 cM (< 350 
kb) marker found by Hanna et al.73). Studies related to the SLC1A1 
gene are described in table 3.
Table 3. Association studies between obsessive-compulsive disorder and the gene SLC1A1
Study design Population Phenotype Sample
Cases/Controls
Results Reference
FB North American Early onset OCD 71 trios Association between two adjacent SNPs of 
the rs301430 on 3’ region (p = 0.03) in whole 
sample and rs3780412 (p = 0.002) in the male 
sample
(153)
FB Caucasian OCD 157 trios rs301434 (c2 = 12.04; p = 0.006) and rs301435 
(c2 = 9.24; p = 0.03)
(152)
FB North American
and French
OCD 66 families rs12682807/rs2072657/rs301430, with higher 
transmission of A/T/T in whole sample (p = 
0.0015) and the male sample (p = 0.0031)
(142)
FB North American OCD 378 families Strong association with the SNP RS301443 
(p = 0.000067; Bonferroni correction  
p = 0.0167) 
154
CC Caucasian OCD 325/662 rs7858819/rs3087879/rs301430 – associated 
with OCD even after correction for multiple 
testing. The haplotype C/C/G was two times 
higher in OCD when compared with controls. 
rs3933331 was associated with hoarding
(167)
OCD: obsessive-compulsive disorder; NS: nonsignificant, CC: case-control; FB: family-based.
183Sampaio AS, et al. / Rev Psiq Clín. 2013;40(5):177-90
Glutamate receptor, ionotropic, kainatos 2 and 3 (GRIK2/
EAA4 and GRIK3/EAA5)
Chromosome: 6, location: 6q16.3-q21, and chromosome: 1, 
location: 1p34-p33, respectively
GRIK2 and GRIK3 contribute to the regulation of inhibitory and 
excitatory transmission and has important roles in physiology and 
plasticity of synapses75. There GRIK2 messenger RNA abundance 
in pyramidal neurons in the caudate, which are involved in the 
pathophysiology of OCD. Animal studies have shown that mice 
with deletion of GRIK2 had significant reduction of fear memory, 
less anxiety behaviors, more exposure to risk and aggressiveness76. 
Genes of GRIK2 and GRIK3 were investigated in a study of 156 OCD 
patients, 141 controls and 124 trios, found that SNP rs2238076 allele 
of GRIK2 was less transmitted than expected for OCD patients (p 
< 0.03). Sampaio et al. also found a significant association between 
the SNP rs1556995 of GRIK2 (p = 0.03), and between rs1556995/
rs1417182 haplotype (p = 0.01) and OCD77.
The gutamatergic system has been the preferred target of the cur-
rent association studies. The association with OCD was identified in five 
studies and a meta-analysis78, but another recent meta-analysis did not 
confirm this association40. A large genome scan study including 1,465 
cases, 5,557 controls matched for ethnicity and 400 trios of OCD pa-
tients found an association with polymorphisms in the gene-associated 
protein SAP90/PSD95- 1 - DLGAP-1, also related to glutamate79.
Gama-aminobutyric acid (GABA) related genes
GABA receptor (GABRR1)
Chromosome: 6; location: 6q13-q16.3
In the only study evaluating this gene in OCD, Zai et al. evaluated 
five polymorphisms in the GABA receptor type 1 (GABBR1) in 159 
families and found a greater transmission of the A allele of A-7265G 
polymorphism in OCD80.
Taking into account that functional neuroimaging studies in 
OCD showed hyperactivity in regions of the orbitofrontal cortex, 
striatum, thalamus, and anterior cingulate81 and that there is an 
inhibitory GABAergic pathways on glutamatergic pathways in these 
regions, genes related to GABA deserve to continue to be evaluated 
in future studies.
Other genes
Brain-derived neurotrophic factor (BDNF)
Chromosome: 11; location: 11p13
The brain-derived neurotrophic factor (BDNF) promotes regen-
eration of brain connectivity and proliferation during development 
and participates in the maintenance and plasticity of neurons even 
during adulthood82. Hall et al. evaluated the BDNF gene in 164 trios 
of probands with OCD and found that the Met66 allele, which alters 
the sequence of pro-BDNF protein was overtransmitted, and may 
confer a protective effect against OCD83. Alonso et al. evaluated 
SNPs in BDNF in 215 OCD patients and 342 controls, and found 
a significant association with a haplotype containing five val66met 
polymorphism markers (p = 0.006 after permutation test, which 
minimizes the risk of false-positive)84. Hemmings et al. found that 
Met66 allele was associated with the OCD in men with early onset 
OCD however, genotype Val66/Val66 was associated with more 
severe OCD in women85. Dickel et al. found no association of poly-
morphisms of genes SLC6A4, HTR1B, HTR2A, and BDNF in 54 
trios of probands with early-onset OCD86. Karterberg and employees, 
trying to replicate these findings, evaluated 419 OCD patients and 
650 controls, but found no significant association between the poly-
morphism val66met (rs6265) and OCD, or any dimension of OCD 
symptoms87. The studies of Mossner and employees, and Wendland 
et al. were also negative88,89.
A meta-analysis found no association between the polymorphism 
and OCD val66met (OR: 1.013, 95% CI: (0.765 to 1.342), p = 0.904)40.
Neurotrophic tyrosine kinase receptor of (NTRK) types 1, 2 
and 3
Chromosome: 1; location: 1q21-q22; chromosome: 9 location: 
9q22.1; chromosome: 15; location: 15q25 (respectively)
Neurotrophic tyrosine kinase receptor of type 3 (NTRK3), high affin-
ity receptor for the neurotrophin 3 (NT-3), was evaluated by Alonso 
et al. in 120 OCD patients and 342 controls, and an association was 
found between the SNP rs7176429 (p = 0, 0001) and hoarding90. 
Alonso et al. also studied the gene of Neurotrophic tyrosine kinase 
receptor type 2 (NTRK2) in 215 OCD patients and 342 controls and 
found an intronic haplotype with a protective effect against OCD (p 
= 0.001) and also that an intronic SNP of NTRK2 (rs2378672) was 
associated with OCD in women (p < 0.0001)84.
Monoamine oxidase A (MAO A)
Chromosome: X; location: Xp11.3
The monoamine oxidase (MAO) is a mitochondrial enzyme that de-
gradetes various biogenic amines, including serotonin, epinephrine, 
norepinephrine and dopamine. Two functional polymorphisms were 
studied in OCD. A polymorphism consists of a 30 bp VNTR located 
above the 1.2kb coding sequences of MAO-A (MAO-Au VNTR) 
and the other is a substitution of T for C (EcoRV) with the T allele 
associated with low enzymatic activity47. There was no association 
between the polymorphism and OCD EcoRV in a meta-analysis40. 
Studies on the MAO-A gene are described in table 4.
Catechol-O-methyltransferase (COMT)
Chromosome: 22; location: 22q11.21
The catechol-O-methyltransferase (COMT) is an enzyme that metab-
olizes catecholamines, including the neurotransmitters norepineph-
rine, epinephrine and dopamine91. The most studied polymorphism 
in the COMT gene is an exchange of single nucleotide (SNP) (val 
158met or rs4680) G to A, which leads to an amino acid substitution 
of valine for methionine at codon 158 of the enzyme. This variation is 
associated with thermolabile form (low activity – 158met allele, allele 
A or allele G) or thermostable (high activity – val158, allele G allele 
or H) of the enzyme92-94. A recent study has shown that OCD patients 
with the G allele of COMT have low levels of 3-O-methyl-DOPA, 
which results from methylation of L-DOPA in plasma95, showing 
that there is a decrease in the activity of the COMT enzyme in OCD 
patients carrying the polymorphism of low activity.
The homozygosity of allele G rs4680 of COMT polymorphism 
results in a decrease to half the enzyme activity and dopamine 
catabolism96,97, with subsequent increase in the availability of dopa-
mine96,98,99, particularly in the prefrontal cortex.
Four meta-analyses of studies of the association between the 
rs4680 polymorphism and OCD had discordant results. The first, 
carried out in 2003100 included case-control and family-based studies 
and found no significant association. The second, made in 2007, only 
with case-control studies (n = 1,908 individuals) found an association 
between OCD and L allele in men but not in women101. This finding 
was replicated in the third meta-analysis that included published case-
control and family-based studies40. However, a fourth meta-analysis, 
with only studies based on families, also found no association with 
OCD102. Studies related to the COMT are described in table 5.
A common feature among BDNF, NKTR, COMT and MAO-A is 
that their functions lead to neuronal pathways in various implications. 
The lack of specificity of their functions may contribute to the incon-
sistent findings in studies of these genes in association with OCD.
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Table 5. Association studies between obsessive-compulsive disorder and the gene of catecol O-methyltransferasis
Study design Population Phenotype  Sample
Cases/Controls
Results Reference
CC White South Africans Hoarding 298/307 NS (136)
CC Israeli OCD + EQZ 113 OCD + EQZ /79 OCD/171 controls NS (168)
CC White North 
Americans
OCD 73/148 LL Genotype and the L 
allele as risk factors for 
OCD in men (p = 0.0002)
(149)  
FB White North 
Americans
OCD 110 families L Allele as risk factor for 
OCD in men (p = 0.008)
(150) 
FB Canadian and North 
American
OCD 67 families Homozygosis for both 
alleles as risk factor for 
OCD (p = 0.006)
(169)
CC White South Africans OCD 54/54 Heterozygosis as risk 
factors for OCD  
(p = 0.002)
(170)
FB Israeli + French +  
North American
OCD 56 families L Alelle as risk factor for 
OCD in women (p = 0.05) (151)
CC Japanese OCD 17/35 NS (171)
CC Turkish OCD 59/114 NS (172)
CC Turkish OCD 79/202 NS (23)
CC Dutch OCD 320 cases LL genotype protects 
against “Tabu” dimension 
of OCD symptoms (p = 
0.06)
(173)
CC Dutch and North 
American
OCD 373/462 Higher frequency of L 
allele in women from 
control group 
(155)
CC Dutch OCD 87/327 Higher frequency of the L 
allele in men with OCD
(101)
FB Chinese OCD 103 trios NS (20)
CC Dutch OCD 159/151 Association between L 
allele and men with OCD 
(p = 0.035)
(51)
L: met allele of the val158met  of the COMT gene; H: val allele of the val158met of the COMT gene; COMT: catecol-O-metiltransferase; OCD: obsessive-compulsive disorder; FB: family-based; YBOCS: 
Yale-Brown Scale of Obsessive-Compulsive Symptoms; Val: Valine; Met: methionine; EQZ: schizophrenia; NS: nonsignificant.
Table 4. Association studies between obsessive-compulsive disorder and the gene of monoamine oxidase-A 
Study design Genotype Population Phenotype Sample
Cases/Controls
Results Reference
FB Exon 8 T/G North American OCD 
OCD + TD vs. 
OCD – TD
110 families
25 families
Allele G as a risk factor for OCD in men (p = 0.02)
Allele G as a risk factor for OCD (p = 0.0004)
(150)
FB
CC
Exon 8 T/G North American OCD 51 families
122/124
Allele T as a risk factor for women with OCD (CC: 
p = 0.02; FB: p = 0.02)
(160)
CC MAO-Au VNTR Korean OCD 121/276 Higher frequency of the 3 repeats allele in men 
with OCD 
(47)
CC Exon 14 T/G 
(EcoRV)
Afrikaners OCD 71/129 NS (165)
MAO-A: monoamine oxidase-A, OCD: obsessive-compulsive disorder; NS: nonsignificant, CC: case-control; FB: family-based.
White matter relatd genes
Transcription factor of the oligodendrocyte lineage (OLIG2; 
BHLHB1 OLIGO2, PRKCBP2, RACK17)
Chromosome: 21; location: 21q22.11
OCD is associated with decreased volume and structural abnormali-
ties of white matter103,104, reflecting a decrease in fractional anisot-
ropy105. The transcription factor of the oligodendrocyte lineage 2 
(OLIG2) is involved in myelination and neurogenesis and is essential 
in regulating the development of cells producing white substance 
(myelin)106. OLIG2 is highly expressed in the amygdala, caudate 
nucleus and thalamus, regions involved in OCD107,108. Stewart et al. 
evaluated 66 families with OCD with or without tic disorders (TT) 
and 33 families of probands with OCD without tic disorders. They 
found an association between OCD without tics in 3 SNP: rs762178 
(p < 0.001), rs1059004 (p = 0.005) and rs9653711 (p = 0.004) in ad-
dition to the association with a haplotype of 5 markers (p = 0.008 
after permutation test)109. These findings have not been replicated.
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Myelin oligodendrocyte glycoprotein (MOG)
Chromosome: 6; location: 6p22.1
OCD may be related to autoimmune processes such as what occurs 
with children who have early symptoms after streptococcal infec-
tion. Furthermore, white matter abnormalities have been reported 
in patients with OCD. One of the candidate genes involved in the 
immune response is myelin oligodendrocyte glycoprotein (MOG), 
which is the mediator of the complement cascade and also plays an 
important role in the formation of white substance. 2 = 6.426, p = 
c2 = 5.255, p = 0.022) and the MOG4 haplotype C1334T.MOG2.
C10991T.MOG4: 1.13.2.2 (Zai et al. found a preferential transmis-
sion of the 459-bp allele (allele 2: 0.011)110. Atmaca et al. evaluated 
genotypes MOG G511C (Val142Leu) and magnetic resonance im-
aging in 30 patients with OCD and 30 controls and found that the 
total white matter volume was greater in patients with OCD who had 
Val/Val genotype of MOG G511C (Val142Leu)111. Genes related to 
white matter in OCD have been studied little and his findings are 
interesting. The evaluation of the association between these genes 
and the change of white matter as an OCD endophenotype, deserve 
to be studied more.
Immune system telated genes
There is evidence to support the involvement of the immune system in 
OCD, as the emergence of OCD associated with rheumatic fever112-114, 
Pediatric Autoimmune Neuropsychiatric Disease with Associated 
Streptococcus (PANDAS)115,116 and evidence that disorders of the 
obsessive-compulsive spectrum aggregate in families of patients 
with rheumatic fever117-119.
Tumor necrosis factor alpha (TNF-alpha)
Chromosome: 6; location: 6p21.3
TNF-alpha is a pro-inflammatory cytokine involved in autoimmune 
diseases such as rheumatic fever. Polymorphisms in the promoter 
region of this gene have been associated with clinical forms of fever120. 
Hounie et al. evaluated111 patients with OCD and 250 controls and 
found an association between OCD and the A allele from the -238 
A/G polymorphism (Chi2 = 12.05, p = 0.0005), the A allele of the 
-308 G/A polymorphism (Chi2 = 7.09, p = 0.007) and AA haplotype 
of these two markers (p = 0.0099)121. Cappi et al. evaluated the same 
polymorphisms in an OCD 83 trios sample, and found that the G 
allele of TNFA 238G/A was overtransmitted to OCD probands (p 
= 0.007) (122). However, Zai et al. found no association between 
TNFA and OCD123.
Nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor-like 1 (NFKBIL1)
Chromosome: 6; location: 6p21.3
Lamb et al. assessed the polymorphism-62A/T NFKBIL1 in 111 OCD 
patients and 272 controls and found no significant association124.
Interleukin-6 (IL-6)
Chromosome: 1; location: 1q21
Cappi et al. evaluated 83 trios with OCD as the rs1800795 polymor-
phism in the promoter region of IL-6 and found no association122.
The TNFA was associated with OCD in two studies, but with 
different alleles. Therefore, this association has yet to be replicated in 
future studies. There is a small number of association studies of genes 
related to immune response and more studies are needed in this area.
Hormone-related genes
Estrogen receptor alpha (ESR)
Chromosome: 6; location: 6q25.1
There is the hypothesis that estrogen-related genes influence the 
clinical presentation of OCD. The postpartum period is a risk for 
the development of obsessive-compulsive symptoms125. Several 
clinical and genetic studies in OCD showed different results for the 
two genders. Among the sex steroids there is evidence that estro-
gens modulate monoamines and neuropeptides (including those 
more related to OCD such as serotonin, dopamine, glutamate and 
GABA) regulate emotional responses, promote neuroprotective 
effects and improve cognition126. Alonso et al. evaluated the gene 
estrogen receptor 1 and 2 (ESR1 and ESR2) in 236 cases with OCD 
and 296 healthy controls; they found that the rs34535804 SNP and 
haplotype of ESR1 five SNPs were significantly associated with extent 
of contamination/cleaning (p = 0.0001) and the frequency of the 
haplotype rs34535804 * A/rs488133 * C/rs9478245 * C/rs2234693 C/
rs9340799 * G * was significantly lower in patients with this symptom 
dimension (p = 0.018)127.
Studies evaluating the association of genes related to estrogen in 
specific subtypes of OCD, such as of early postpartum OCD or late 
onset OCD in females as well as the investigation of genes related 
to oxytocin could help in understanding the mechanisms by which 
there is an increased risk of developing OCD after the birth of a child 
or in the postpartum period128-130.
Discussion
There is a body of evidence that biological/genetic expression is im-
portant in OCD. The genetic segregation model that best explained 
OCD is the complex model in which the influences of several genes 
with small effects are in interaction with environmental factors. 
Seve ral studies with candidate genes have been performed for various 
reasons and their findings are not conclusive.
Possible explanations for the diversity of results and low rep-
licability are its small sample size and the low statistical power of 
most studies. Moreover, many of them conducted multiple analyses 
without adequate statistical correction to its results, which increases 
the chance of false positives.
Another possible explanation for the diversity of results is the 
phenotypic heterogeneity of OCD. There is a hypothesis that differ-
ent subgroups of TOC can receive influence from different genes. 
The subgroups of OCD can be organized by gender, age at onset 
of symptoms and comorbid tics131,132. There is also an attempt to 
subdivide the TOC according to the size of symptoms because they 
would relate to a different neurobiological substrate. Hoarding, for 
example, has specific features on the epidemiology, treatment re-
sponse in neuroimaging findings133-136 and genetic findings137. As for 
comorbid tics, there is evidence of involvement of the dopaminergic 
system in OCD138 and there were even found positive findings of 
association between certain genes related to dopamine and OCD 
with comorbid tic disorders49,50,57. OCD also is genetically linked to 
Tourette syndrome139,140 which was associated with dopamine-related 
genes such as the gene for dopamine D2 receptor (DRD2)141-143, 
dopamine receptor D4 (DRD4)144, dopamine transporter (DAT)145, 
and monoamine oxidase A (MAO-A)144. It is possible that OCD in 
comorbid tic disorders configure a separate subgroup with suscepti-
bility associated with polymorphisms in genes related to dopamine. 
OCD can also be heterogeneous between genders. Several genetic 
association studies showed there were differences when analyzed 
separately by gender16,17,51,85,101, 146-155. The same is seen when the 
sample is divided according to age at onset of TOC18,20,56,68,86,153,156. 
These two characteristics are used to group individuals with OCD 
in more homogeneous subgroups131.
The use of quantitative traits (such as severity scores of YBOCS), 
endophenotypes, studies of gene-environment interaction and 
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epigenetic studies are the next steps in association studies in OCD. 
Possible investigations of interaction between genes and environment 
in OCD include the role of polymorphisms in the development of 
OCD after traumatic events, or streptococcus infection, or even the 
influence of polymorphisms in the development of personality traits 
risk for OCD157. The definition of endophenotypes by neuroimag-
ing studies, neurophysiology and neuropsychology are essential in 
guiding genetic studies157.
Conclusion
The amount of available data does not allow us to pinpoint a gene 
responsible for the etiology of OCD. Establishing groups with more 
homogeneous phenotypes may improve the accuracy of results. 
Association studies with a large sample size, sometimes achieved 
through consortia and meta-analyses are still needed.
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